Marta E. Bryskiewicz
Dobra, MA 72003, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Blood molybdenum level as a marker of cancer risk on BRCA1 carriers.
Journal: Hereditary cancer in clinical practice
Published: August 01, 2024
Antioxidant Properties of Zinc and Copper-Blood Zinc-to Copper-Ratio as a Marker of Cancer Risk BRCA1 Mutation Carriers.
Journal: Antioxidants (Basel, Switzerland)
Published: June 05, 2024
Cobalt Serum Level as a Biomarker of Cause-Specific Survival among Prostate Cancer Patients.
Journal: Cancers
Published: May 31, 2024
Blood Lead Level as Marker of Increased Risk of Ovarian Cancer in BRCA1 Carriers.
Journal: Nutrients
Published: March 26, 2024
Blood Iodine as a Potential Marker of the Risk of Cancer in BRCA1 Carriers.
Journal: Nutrients
Published: March 23, 2024
Zinc and Its Antioxidant Properties: The Potential Use of Blood Zinc Levels as a Marker of Cancer Risk in BRCA1 Mutation Carriers.
Journal: Antioxidants (Basel, Switzerland)
Published: March 23, 2024
Correlation between Selenium and Zinc Levels and Survival among Prostate Cancer Patients.
Journal: Nutrients
Published: January 11, 2024
Risk of Second Primary Thyroid Cancer in Women with Breast Cancer.
Journal: Cancers
Published: December 03, 2021
HbA1c Screening for Diabetes in Patients with Acute Coronary Syndrome: A Worthwhile Test or a Pitfall?
Journal: Journal of clinical medicine
Published: August 09, 2021
Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes.
Journal: Nature communications
Published: June 17, 2019
Last Updated: 09/26/2026